Abstract: An implantable medical device and method for adjustably restricting a selected body lumen such as a urethra or ureter of a patient to treat urinary incontinence or ureteral reflux. The device includes an adjustable, self-sealing element having a continuous wall, including an inner surface defining a chamber. The adjustable element expands or contracts due to fluid volume introduced into the chamber for restricting a body lumen. After being implanted into a patient, the size of the adjustable element is altered by first locating the adjustable element implanted adjacent the body lumen, and then establishing fluid communication with the adjustable element. The volume of the adjustable element is then adjusted by either introducing or removing volume from the chamber of the adjustable element.

Abstract: The invention concerns a prosthesis (2) designed to be inserted between two neighboring vertebrae, comprising a core (4) made of an elastic material and covered, over part of its periphery, with a rigid material coating (6) designed to be in contact with the two neighboring vertebrae. The core (4) comprises, in transverse cross-section, two end portions (8) linked by a median portion (12) and said coating includes two caps provided with a threading and covering at least partially the external periphery of the end portions (8), the distance separating the caps increasing towards the prosthesis front part.

Abstract: A medical device, such as a stent or balloon of a balloon catheter which includes a body portion which has an exterior surface which contacts, at least in part, a vessel wall during treatment. The body portion is expandable from a first position, wherein the body portion is sized for insertion into the vessel lumen, to a second position, wherein at least a portion of the exterior surface is in contact with the lumen wall. The medical device includes a first coating disposed over at least a portion of the exterior surface of the body portion with the first coating including a drug or therapeutic substance which is intended for controlled release from the surface. The medical device further includes a second coating overlying at least a substantial portion of the first coating. The second coating includes a material that is generally impervious to elution of the drug or therapeutic substance therethrough when the body portion is in a first position when inserted into the vessel lumen.

Abstract: Living nucleus pulposis cells and extracellular matrix obtained from recently deceased human or animal donors are used to restore disc function and eliminate pain in patients with disc disease. In the preferred embodiment, the donor nucleus is morselized to allow insertion through a small puncture in the annulus fibrosis with a needle and syringe. Additional therapeutic substances like culture medium, growth factors, differentiation factors, hydrogels polymers, antibiotics, anti-inflammatory medications, or immunosuppressive medications could be added to the transplanted nucleus pulposis tissue.

Abstract: An implant, in particular an intervertebral endoprosthesis, with a connection plate (3) which is to be fixed so as to bear on a bone surface and which is to be applied to the bone surface in a direction of application running transverse to its main extension. For protection against a shearing force running parallel to its main extension, the connection plate (3) has teeth (6) projecting in the direction of application. These teeth (6) are delimited by surfaces (11, 12, 13) which include a main surface (11) arranged in the direction of application and transverse to the direction of shearing. Two teeth or groups of teeth in each case lie opposite one another in the direction of shearing and point in opposite directions.

Abstract: Open chambered spacers, implanting tools and methods are provided. The spacers 500′ include a body 505′ having a wall 506′ which defines a chamber 530′ and an opening 531′ in communication with the chamber 530′. In one embodiment the wall 506′ includes a pair of arms 520′, 521′ facing one another and forming a mouth 525′ to the chamber 530′. Preferably, one of the arms 520′ is truncated relative to the other, forming a channel 526. In one aspect the body 505′ is a bone dowel comprising an off-center plug from the diaphysis of a long bone. The tools 800 include spacer engaging means for engaging a spacer and occlusion means for blocking an opening defined in the spacer. In some embodiments, the occlusion means 820 includes a plate 821 extendable from the housing 805.

Abstract: A stent consisting of at least two parts in juxtaposition, one part being of self-expandable characteristics while the other part is balloon expandable.

Abstract: A static device for use with the heart that has a plurality of members configured to be positioned adjacent the epicardial surface of the heart. The members are joined by at least one connector wherein the members are fixed in a spatial or spaced relationship relative to each other such that a portion of the heart wall is displaced inwardly. The member(s) can be configured in a rectangular shape, and preferably includes an inner surface having a curved configuration. In one embodiment, the device can have first and second member that are positioned in a spaced relationship relative to each other about 180 degrees apart. The first member is configured to be positioned adjacent the anterolateral surface of the chamber, and the second member configured to be positioned adjacent the posteromedial surface of the chamber.

Abstract: The present invention provides a prosthetic cover (12) shaped to form a replacement nucleus pulposis (56) for an intervertebral disc (50), said cover comprising a permeable layer of an immunologically neutral material terminating in a valve structure (16) to allow the introduction of a hydrogel material (14); characterized in that a transudative material is disposed on the intended inner face of the cover to allow a through flow of low molecular weight materials only.

Abstract: A vascular or endoluminal stent has low surface friction for ease of navigating a vessel, duct or tract of a patient. The stent is configured as a tubular element of biocompatible material having a longitudinal axis, open ends and a multiplicity of openings of generally common shape and size through its wall throughout its length. The openings are bounded by a network of tangentially interconnected, continuous, predominantly longitudinally oriented curvilinear struts, without discontinuity, forming a sidewall of the tubular element. The stent is adapted to be deployed by exertion of outward radial pressure on the tubular element, and when deployed, at least a segment of each strut undergoes a transition to a predominantly transverse orientation relative to the longitudinal axis of the stent.

Abstract: Laterally expanding vertebral spacer devices are provided for repairing damaged vertebral discs. The vertebral spacer devices maintain the height of a distracted vertebral disc space while providing stability to the spine. In one form of the invention, a vertebral spacer device is provided with a first arm movably coupled to a second arm. The first and second arms are laterally expandable from a first width for insertion into the disc space to a second width after insertion into the disc space. The first and second arms also define a cavity therebetween for placement of bone growth material.

Abstract: A metal stent for vascular implantation comprising a generally tubular structure whose external surface is adapted to engage the interior vascular surface when implanted, said metal of said stent containing a substantially uniform dispersion of from about 0.05 to about 10.00 percent by weight of one or more naturally occurring or enriched stable isotopes having a half-life of less than two months and that are principally beta particle emitters, so that when activated, said stent emits low to moderate dosages of radiation uniformly to reduce cell proliferation.

Abstract: Apparatus and methods are disposed for maintaining the proper positioning of a prosthetic implant having proximal and distal ends within a prepared bone cavity during cement injection and curing. First stabilization means, implantable within the bone cavity, minimize lateral movement of the distal end of the implant, while second stabilization means, physically separate from the means for minimizing lateral movement of the distal end of the implant, minimize both the lateral movement of the proximal end of the implant and the rotational movement of the implant overall. In the preferred embodiment, the second stabilization means includes an apertured cap removably securable to the end of a bone having the prepared cavity through which the implant is inserted and held in place.

Abstract: A metal stent for vascular implantation comprising a generally tubular structure whose extend surface is adapted to engage the interior vascular surface when implanted, said metal of said stent containing a substantially uniform dispersion of from about 0.05 to about 10.00 percent by weight of one or more naturally occurring or enriched stable isotopes having a half-life of less than two months and that are principally beta particle emitters, so that when activated, said stent emits low to moderate dosages of radiation uniformly to reduce cell proliferation.

Abstract: A stent having at least one smooth end is disclosed. The stent may include a coating or coatings on one or both end portions to provide a smooth finish to reduce possible damage to body passages when the stent is deployed and delivered. The stent may also contain drugs or surgical adhesives or a combination thereof in or on the coated portion of the stent. The stent may also be of the type where the materials of the stent may be treated to have a smooth flexible end or ends. The stent may also be of a configuration such that at least one end is more flexible than the middle portion of the stent.

Abstract: A prosthesis has a cylindrical stent, and a cover provided about the outer periphery of the stent. The cover has at least two layers of materials, with at least one layer of material being permeable to drugs. The layers of material can define at least one chamber therebetween, with a drug loaded into the at least one chamber. Alternatively, the drug can be loaded into the material of one or more layers.

Abstract: Apparatus and methods aid the annulus in controlling vertebral motion, thereby preventing additional annular tears, and decreasing pain from annular tears. A biocompatible fabric or mesh is attached to the annulus. The material may be attached to the inside and/or outside of the annulus by stitches, staples, adhesives, or other suitable techniques. Alternatively, the fabric may be attached to the vertebra above and below the disc by screws, staples, tacks, or porous material for bone ingrowth such as titanium.

Abstract: A trileaflet biological prosthetic heart valve comprising a thin, rigid annular outer frame which supports three elastic, laminated spring inner frames which in turn provide consistent geometric form and structure for attachment of tissue leaflets.

Abstract: A bone joining implant, comprising a tubular body having an open leading end and a central aperture, the central aperture similarly sized to the open leading end, the open leading end communicating with the central aperture and configured to entrap a bone projection from each of a pair of adjacent bone bodies being joined together. A method is also provided.

Abstract: An annuloplasty prosthesis for supporting an annulus of a heart valve includes a substrate material over which a covering of a biocompatible and biological tissue material is applied. The substrate may be formed of a generally rigid material (e.g., a plastic or metal) in which the substrate has a predetermined shape corresponding to an annulus of the heart valve. Alternatively, the substrate may be formed of flexible material (e.g., a soft cloth or natural tissue), which may be adjusted at implantation to accommodate the size and configuration of annulus.